Delivery Order SPE2DB24D2205-SPE2DB25FEJBM
- Not listed
- The Defense Logistics Agency awarded a $28,423.85 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tobi Podhaler 28 mg inhalable capsules (56-count unit dose). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is set for completion by September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same city. The...
- The Defense Logistics Agency awarded a $33,712.95 delivery order to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency awarded a $26,268.09 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tobi Podhaler 28 mg inhale capsules (56-unit doses). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $41,719.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pediatric and adult cystic fibrosis treatment, positioning the pharmaceutical...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,745.92, is for the delivery of 4,562,406,339 units of TOBI PODHALER 28 MG INHALE CAP UD 56S, with an ultimate completion date of October 6, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,972.30, is for the supply of the pharmaceutical product Tobi Podhaler 28 mg inhalation capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,186.01 firm fixed-price delivery order is for the supply of 4562300741 Tobi Podhaler 28 mg inhalation capsules. The contract has a completion date of September 26, 2023 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,075.64 firm fixed-price delivery order is for the supply of 4,566,359,280 units of the medication Tobi Podhaler 28 mg inhalation capsules. The contract has an ultimate completion date of November 7, 2024 and was awarded on November 6, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at twenty-eight thousand six hundred sixty-three dollars and twenty-nine cents ($28,663.29) to Amerisourcebergen Drug Corporation for TOBI PODHALER 28 MG INHALE CAPSULES UD 56S. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning August 4, 2023 through August 7, 2023 to supply pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,472.14 contract is for the supply of 4,563,348,474 units of the TOBI PODHALER 28 MG INHALE CAP UD 56S pharmaceutical product. The award is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of pharmaceutical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEJBMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $93,709.93 to AmerisourceBergen Drug Corp for Tobi Podhaler 28 mg inhalable capsules (56-unit dose packages) on September 25, 2025, with completion scheduled for September 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This delivery order represents a continuation of AmerisourceBergen Drug Corp's ongoing role as a critical supplier to federal military and veteran healthcare systems through the DLA Medical Supply Chain. The contractor's extensive portfolio of pharmaceutical deliveries spans multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Tobi Podhaler is an inhaled antibiotic used primarily for treating respiratory infections in cystic fibrosis patients, reflecting the breadth of specialized medical products the contractor provides to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.7k | 9/25/25 |